677 related articles for article (PubMed ID: 25583328)
1. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
2. CDK6 mediates the effect of attenuation of miR-1 on provoking cardiomyocyte hypertrophy.
Yuan W; Tang C; Zhu W; Zhu J; Lin Q; Fu Y; Deng C; Xue Y; Yang M; Wu S; Shan Z
Mol Cell Biochem; 2016 Jan; 412(1-2):289-96. PubMed ID: 26699910
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy.
Li Q; Song XW; Zou J; Wang GK; Kremneva E; Li XQ; Zhu N; Sun T; Lappalainen P; Yuan WJ; Qin YW; Jing Q
J Cell Sci; 2010 Jul; 123(Pt 14):2444-52. PubMed ID: 20571053
[TBL] [Abstract][Full Text] [Related]
5. Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading.
Wohlschlaeger J; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Stypmann J; Schmid C; Baba HA
J Heart Lung Transplant; 2010 Jan; 29(1):117-24. PubMed ID: 20123249
[TBL] [Abstract][Full Text] [Related]
6. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a.
Wei L; Yuan M; Zhou R; Bai Q; Zhang W; Zhang M; Huang Y; Shi L
J Cardiovasc Pharmacol; 2015 Apr; 65(4):357-63. PubMed ID: 25850725
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
12. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
13. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.
Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro.
Busk PK; Bartkova J; Strøm CC; Wulf-Andersen L; Hinrichsen R; Christoffersen TE; Latella L; Bartek J; Haunsø S; Sheikh SP
Cardiovasc Res; 2002 Oct; 56(1):64-75. PubMed ID: 12237167
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.
Busk PK; Hinrichsen R; Bartkova J; Hansen AH; Christoffersen TE; Bartek J; Haunsø S
Exp Cell Res; 2005 Mar; 304(1):149-61. PubMed ID: 15707582
[TBL] [Abstract][Full Text] [Related]
17. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
19. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
Duan Y; Zhou B; Su H; Liu Y; Du C
Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
[TBL] [Abstract][Full Text] [Related]
20. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
